medical cannabinoids

| Article

Newswise — Residents of states where cannabis has been legalized are more likely to believe it has beneficial effects - including health benefits in treatment of pain and anxiety or depression, reports a survey study in the Journal of Addiction Medicine, the official journal of the American Society...

| Article

Newswise — A team of researchers at the University of Georgia will study how legalized medical cannabis affects people living with chronic pain.

To date, 34 states and the District of Columbia have adopted medical cannabis laws, or MCLs, which legalize either home cultivation or dispensary-based...

| Article

Newswise — Using the largest database of real-time recordings of the effects of common and commercially available cannabis products in the United States (U.S.), researchers at The University of New Mexico (UNM) found strong evidence that cannabis can significantly alleviate pain, with the average...

| Podcast

Medical and recreational marijuana are sources of great confusion to patients and clinicians alike. A culture of “neuromysticism” around medical marijuana has arisen, leaving patients and clinicians muddled regarding what constitutes “medical” marijuana. This is due in part to the poor quality of...

| Article

Newswise — Millennials lead the escalating interest in marijuana and cannabinoid compounds for managing pain – with older generations not far behind – and yet most are unaware of potential risks. Three-quarters (75%) of Americans who expressed interest in using marijuana or cannabinoids to address...

| Article

Newswise — Marijuana increased in popularity in the mid-1970s when there was interest in cannabinoids for reduction in intraocular pressure (IOP), which is the fluid pressure inside the eye. Now, its usage has increased due to its pleasure-inducing side effects, and behind tobacco, alcohol and...

| Article

As has been frequently noted by different contributors to the PAINWeek platform, there is a range of opinion on the safety and efficacy of medical cannabis, brought on in no small part by the dearth of clinical study resulting from current federal regulatory status. New research from the University...

| Article

A research team composed of members from China, Russia, and the US have announced a significant advance in understanding the structure of CB2, one of 2 cannabinoid receptors in the human endocannabinoid system. Cannabinoid receptors can be targeted to address a range of pathological conditions,...

| Article

An article and accompanying editorial published this month in the Canadian Journal of Cardiology reinforces other warnings concerning the adverse cardiovascular effects of medical cannabis, especially in older patients. The authors relate the case of a 70-year-old male patient with chronic pain and...

Subscribe to medical cannabinoids

Sign Up

Subscribe to the PAINWeek Newsletter
and get our latest articles and more directly in your inbox.